Follow-up notice on the shortage of Diamox 250 mg tablets (acetazolamide)
03.03.2015
Following to the previous notice on the shortage of Diamox 250 mg tablets (acetazolamide) on the Croatian market, the marketing authorisation holder for this medicinal product, Medical Intertrade d.o.o. has notified the Agency for Medicinal Products and Medical Devices on the shortage prolongation.
The normalisation of the supply chain with Diamox 250 mg tablets is expected in June 2015. By that time, patients will be treated with a medicinal product without a Croatian marketing authorisation that will be entered into the country by using the legal exemption scheme.
